Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma

doi:10.5306/wjco.v15.i1.62

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2424)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-15) series.

Item

Count

PDF

WORD

HTML

1249

Figures (1-15)

172

Sum=1499

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

100

Download

224

Sum=324

Publishing Process of This Article

Item

Count

Browse

137

Download

379

Sum=516

Jan 24, 2024 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Jan 24, 2024; 15(1): 62-88
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.62

Full Size Figure Download Figure

Figure 6 The identification and mRNA expression of five key genes in transcatheter arterial embolisation treated hepatocellular carcinoma. A: Five key genes were identified using Maximal Clique Centrality method of the cytoHubba plugin. B: The mRNA expression level of the five key genes in hepatocellular carcinoma samples of transcatheter arterial embolisation (TACE) non-responders and TACE responders. DLGAP5: DLG-associated protein 5; KIF20A: Kinesin family member 20A; ASPM: Assembly factor for spindle microtubules; KIF11: Kinesin family member 11; TPX2: TPX2 microtubule nucleation factor.

Citation: Huang JZ, Li JD, Chen G, He RQ. Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma. World J Clin Oncol 2024; 15(1): 62-88
URL: https://www.wjgnet.com/2218-4333/full/v15/i1/62.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i1.62